T1	intervention 10 31	intravenous lidocaine
T2	eligibility 61 91	patients undergoing mastectomy
T3	No-of-participants 619 630	Seventy-one
T4	eligibility 631 672	patients undergoing breast cancer surgery
T5	control 714 721	placebo
T6	control-participants 736 738	34
T7	intervention-participants 770 772	37
T8	outcome-Measure 912 965	Intraoperative and postoperative morphine consumption
T9	outcome-Measure 982 1013	Postoperative pain scores, PONV
T10	outcome-Measure 1019 1026	fatigue
T11	outcome-Measure 1079 1118	Duration of postoperative hospital stay
T12	outcome 1233 1285	intraoperative or postoperative morphine consumption
T13	outcome 1328 1374	Overall pain scores either at rest or activity
T14	outcome 1416 1420	PONV
T15	outcome 1434 1441	fatigue
T16	outcome 1458 1497	duration of postoperative hospital stay
